Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Clinical trial NCT00068393 · COMPLETED

Trial details

NCT number: NCT00068393
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Renal Cell Carcinoma With Sarcomatoid Features

Start date: 2004-02-24
Primary completion: 2009-06-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.